跳至主要内容
临床试验/NCT07815691
NCT07815691尚未招募2 期

The Contribution of the Endocannabinoid System to Sex Differences in THC-associated Reward

Medical University of South Carolina1 个研究点 分布在 1 个国家目标入组 78 人开始时间: 2026年9月15日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
2 期
状态
尚未招募
入组人数
78
试验地点
1
主要终点
Nucleus accumbens glutamate

研究概览

简要总结

This study will examine sex differences in the effects of cannabis in people that regularly use it. Men and women that use cannabis at least 4 days a week will participate in a study involving 3 in-person visits. The first visit will be used to determine eligibility for the study. The other two visits will last 7 hours each and take place at least two days apart. Visits include administration of either THC, the chemical responsible for many of the psychoactive effects of cannabis, or a placebo; completion of questionnaires; and a 1-hour brain scan. One visit will also include a blood draw for genetic testing.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Crossover
主要目的
Basic Science
盲法
Double (Participant, Investigator)

入排标准

年龄范围
21 Years 至 45 Years(Adult)
性别
All
接受健康志愿者

入选标准

  • Able and willing to provide informed consent
  • Meet DSM-5 criteria for CUD
  • Report cannabis use ≥4 days/week on average in the last 30 days at screening
  • Provide a THC-positive urine sample at screening
  • BMI between 18-30 kg/m2
  • Regular menstrual cycle (females only)
  • Willing to use non-hormonal birth control for the duration of study participation (females only)

排除标准

  • Meet DSM-5 criteria for any lifetime psychotic or bipolar disorder
  • Urinalysis results indicative of recent drug use other than cannabis
  • Current use of any psychotropic medication or over-the-counter supplements deemed by the investigator to have the potential to interfere with study outcomes
  • Current treatment-seeking for CUD or other SUDs
  • Meet DSM-5 criteria for any current psychiatric disorder other than nicotine or caffeine use disorder, mild alcohol use disorder, CUD, or ADHD
  • Females who are pregnant, nursing, or planning to become pregnant
  • MRI contraindications (e.g., metallic implants, claustrophobia)
  • Significant history of nausea associated with the use of cannabis and/or THC
  • History of cardiac or seizure disorders
  • Allergy to sesame oil

研究组 & 干预措施

Males

Other

干预措施: Placebo (Drug)

Females

Other

干预措施: Placebo (Drug)

Males

Other

干预措施: Dronabinol (Drug)

Females

Other

干预措施: Dronabinol (Drug)

结局指标

主要结局

Nucleus accumbens glutamate

时间窗: 2 hours post-dose

Concentrations of nucleus accumbens glutamate measured via proton magnetic resonance spectroscopy

Drug Effects Questionnaire (DEQ) - Like Drug Effect

时间窗: 0-7 hours post-dose

Visual Analog Scale rating of subjective drug liking included in the Drug Effects Questionnaire. Score ranges from 0 (not at all) to 100 (extremely) using a 100mm line anchored with none/extreme designation.

Sex differences in genetics

时间窗: Day 1

Blood-based DNA sample will be tested for genetic variants of interest involved in the endocannabinoid system

次要结局

  • Dorsal striatal glutamate(2 hours post-dose)
  • Drug Effects Questionnaire (DEQ) - Want More(0-7 hours post-dose)
  • Drug Effects Questionnaire (DEQ) - High(0-7 hours post-dose)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Erin Martin

Assistant Professor

Medical University of South Carolina

研究点 (1)

Loading locations...

相似试验